Clinical trials in Leiderdorp – page 2

41 clinical trials in Leiderdorp, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Leiderdorp at a glance

clinical trials

Paediatric trials0
Research sites1

Quick filters

41 trials in Leiderdorp

Open in trial search

Neoplasm

Recruiting

Registered drugNo placebo

Study on the Effects of Removing Dexamethasone from Premedication in Paclitaxel Treatment for Patients with Solid Tumors

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Dexamethasone
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study on Treatment-Free Intervals for Newly Diagnosed Multiple Myeloma Patients Using Daratumumab, Lenalidomide, and Dexamethasone

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Daratumumab
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Dose-Reduced Oxaliplatin and Drug Combination Study for Older Patients with Metastatic Colorectal Cancer

Registered drugNo placebo

The Netherlands

Participants:65+ years
Substances:Capecitabine
Sponsor:Leids Universitair Medisch Centrum (LUMC)

Contact Research Centre

Hepatic cirrhosis

Recruiting

Registered drug

Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin
Sponsor:European Foundation For The Study Of Chronic Liver Failure

Contact Research Centre

Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

Recruiting

Registered drugNo placebo

Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Clindamycin
Sponsor:Leids Universitair Medisch Centrum (LUMC)

Contact Research Centre

Pancreatic carcinoma+1

Recruiting

Registered drugNo placebo

Study on Timing of Chemotherapy with Paclitaxel Albumin-Bound and Drug Combination for Patients with Metastatic Pancreatic Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Amsterdam UMC

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Registered drug

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Obesity+2

Not yet recruiting

Investigational

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational

The Netherlands

Participants:18–64 years
Sponsor:Novo Nordisk A/S

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Investigational

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Hepatic cirrhosis

Not yet recruiting

Registered drugNo placebo

Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin
Sponsor:Amsterdam UMC

Contact Research Centre

Arteriosclerosis

Not recruiting

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Chronic rhinosinusitis with nasal polyps

Not recruiting

Investigational

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Itepekimab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Leiderdorp

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on cardiovascular disease prevention and treatment, including trials evaluating new therapies for heart failure and atrial fibrillation.

Lipoprotein management therapies
Heart failure treatments
Stroke prevention methods

Multiple innovative treatments being tested to reduce major cardiovascular events and improve patient outcomes.

02 Oncology Studies

Comprehensive research into various cancer treatments, with particular focus on breast cancer and colorectal cancer therapeutic approaches.

Advanced breast cancer treatments
Colorectal cancer therapies
Personalized treatment strategies

Studies evaluating novel drug combinations and treatment protocols for various stages of cancer.

03 Neurological Disorders

Innovative research focusing on multiple sclerosis treatment optimization and personalized dosing strategies.

MS treatment personalization
Drug interval optimization
Comparative therapy studies

Advanced trials exploring more effective and tailored treatment approaches for neurological conditions.

Back to the Netherlands All countries